Mitchell, M S <br/><br/>
Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.  [electronic resource] 

 -  Cancer research  Oct 1988 
 - 5883-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Hypersensitivity, Delayed<br/>Immunization, Passive<br/>Lymphatic Metastasis<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>T-Lymphocytes, Cytotoxic--analysis